HRV Pharma, Haleos Labs partner to develop, manufacture orphan and niche APIs
HRV Pharma and Haleos Labs have joined forces in a multi-year strategic partnership to fast-track the development and manufacturing of specialized active pharmaceutical ingredients (APIs) for rare diseases and niche therapies. This collaboration leverages HRV’s global market access and Haleos’ manufacturing expertise to introduce 5-7 new high-value molecules annually, targeting underserved patient populations worldwide.🕒 1 min read
HRV Pharma and Haleos Labs have joined forces in a multi-year strategic partnership to fast-track the development and manufacturing of specialized active pharmaceutical ingredients (APIs) for rare diseases and niche therapies. This collaboration leverages HRV’s global market access and Haleos’ manufacturing expertise to introduce 5-7 new high-value molecules annually, targeting underserved patient populations worldwide.
Continue Reading
-
Suniel Shetty Receives “Most Precious” Birthday Gift From Granddaughter Evaraah – See Pic
-
Yashasvi Jaiswal Has ‘Animated Chat With India Coach Gautam Gambhir: Report. Star Then Does This In Nets
- India vs Namibia LIVE Updates, T20 World Cup: Suryakumar Yadav Gives Concerning Abhishek Sharma Update, India Make 2 Changes
- Economic Growth Strongest Form Of Financial Inclusion: Chief Economic Adviser
- NDTV Bihar Election Conclave Live Updates: State Set For Pre-Poll Showdown
- Twisha Sharma Cremated After 2nd Autopsy In Dowry Harassment Case
-
‘Met targets’: IMF defends $1bn bailout package to Pakistan despite India’s pushback
- Maharashtra Man Kills Minor Fiancee After Fight, Arrested
- Stock Market Live Updates: Nifty50 ends below 24,000; BSE Sensex down over 400 points as high oil prices, weak global sentiment weigh
- JD Vance May Travel To Pakistan For Iran War Talks Over Weekend: Report
